Status:
UNKNOWN
Predictive Model for Prognosis of Chronic HBV Infection Mothers
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Collaborating Sponsors:
the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Conditions:
Hepatitis B, Chronic
Eligibility:
FEMALE
20-45 years
Brief Summary
Pregnancy is a complex and coordinated physiological process. Pregnancy and the postpartum period are associated with unique changes in the immune system that may impact the natural history of autoimm...
Eligibility Criteria
Inclusion
- Age 20-45 years old
- Serum HBsAg positive\> 6 months
- HBeAg positive at delivery
- Good compliance
Exclusion
- Women who give birth to stillbirth due to various reasons
- Coinfection with HIV,HCV, syphilis or other sexually transmitted diseases
- Severe kidney, cardiovascular, lung, nervous system or immune system diseases
- Who are taking immunotherapy drugs or anti-tumor drugs
Key Trial Info
Start Date :
April 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT04805034
Start Date
April 16 2021
End Date
January 31 2024
Last Update
August 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710061